TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.235
+0.115 (10.27%)
At close: Mar 9, 2026, 4:00 PM EDT
1.230
-0.005 (-0.40%)
After-hours: Mar 9, 2026, 4:00 PM EDT
TScan Therapeutics Employees
As of December 31, 2024, TScan Therapeutics had 195 total employees, including 146 full-time and 2 part-time employees. The number of employees increased by 41 or 26.62% compared to the previous year.
Employees
195
Change (1Y)
41
Growth (1Y)
26.62%
Revenue / Employee
$69,764
Profits / Employee
-$876,797
Market Cap
70.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 195 | 41 | 26.62% |
| Dec 31, 2023 | 154 | 16 | 11.59% |
| Dec 31, 2022 | 138 | 33 | 31.43% |
| Dec 31, 2021 | 105 | 47 | 81.03% |
| Dec 31, 2020 | 58 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InflaRx | 74 |
| Mereo BioPharma Group | 36 |
| eXoZymes | 31 |
| Q32 Bio | 26 |
| NeurAxis | 21 |
| Annovis Bio | 15 |
| Instil Bio | 14 |
| MediciNova | 13 |
TCRX News
- 5 days ago - TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03 - GlobeNewsWire
- 12 days ago - TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities - GlobeNewsWire
- 4 months ago - TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 4 months ago - TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 - GlobeNewsWire
- 6 months ago - TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025 - GlobeNewsWire